Methotrexate treatment in juvenile localized scleroderma: A randomized, double-blind, placebo-controlled trial
Methotrexate treatment in juvenile localized scleroderma: A randomized, double-blind, placebo-controlled trial is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Methotrexate treatment in juvenile localized scleroderma: A randomized, double-blind, placebo-controlled trial have?
Methotrexate treatment in juvenile localized scleroderma: A randomized, double-blind, placebo-controlled trial has 216 citations in the OpenAlex counts ScholarIQ stores.
When was Methotrexate treatment in juvenile localized scleroderma: A randomized, double-blind, placebo-controlled trial published?
Methotrexate treatment in juvenile localized scleroderma: A randomized, double-blind, placebo-controlled trial has 2011 year in the ScholarIQ index.
What is the open-access status of Methotrexate treatment in juvenile localized scleroderma: A randomized, double-blind, placebo-controlled trial?
Methotrexate treatment in juvenile localized scleroderma: A randomized, double-blind, placebo-controlled trial has closed oa status in the ScholarIQ index.
What is the DOI of Methotrexate treatment in juvenile localized scleroderma: A randomized, double-blind, placebo-controlled trial?
The DOI for Methotrexate treatment in juvenile localized scleroderma: A randomized, double-blind, placebo-controlled trial is on the source record.
What is the PMID of Methotrexate treatment in juvenile localized scleroderma: A randomized, double-blind, placebo-controlled trial?
The PMID for Methotrexate treatment in juvenile localized scleroderma: A randomized, double-blind, placebo-controlled trial is on the source record.
What is the OpenAlex record for Methotrexate treatment in juvenile localized scleroderma: A randomized, double-blind, placebo-controlled trial?
The OpenAlex for Methotrexate treatment in juvenile localized scleroderma: A randomized, double-blind, placebo-controlled trial is on the source record.